サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1529766

止血バルブの市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

Hemostasis Valve Market Size, Share & Trends Analysis Report By Type, By Application (Angiography, Angioplasty), By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 110 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.57円
止血バルブの市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年
出版日: 2024年07月15日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

止血バルブの市場規模と動向

止血バルブの世界市場規模は2023年に1億7,480万米ドルと推定され、2024～2030年にかけてCAGR 5.8%で成長すると予測されています。心血管疾患の有病率の増加、支持的な規制の枠組み、高齢者人口の増加、技術の進歩が市場成長を大きく促進しています。世界心臓連盟が2023年に発表した報告書によると、心血管疾患（CVD）は世界的に深刻な影響を及ぼしており、世界で5億人以上が罹患し、2021年には約2,050万人が死亡しています。このため、血管造影術や血管形成術のような診断・治療手技の需要が高まっており、カテーテル治療中に血流を制御して患者の安全を確保するためには止血バルブが不可欠です。

低侵襲手技への嗜好の高まりも市場成長を後押しする重要な要因です。低侵襲手技は、従来の開腹手術に比べて、痛みの軽減、入院期間の短縮、回復時間の短縮、合併症リスクの低下など、数多くの利点を記載しています。その結果、これらの手技を容易にする医療機器に対する需要が高まっています。止血バルブは、血流の正確なコントロールを可能にし、手技中の漏れを防ぐため、カテーテルを用いた低侵襲インターベンションには不可欠です。心臓病学やその他の医療セグメントにおける低侵襲技術へのシフトが止血バルブの採用を後押ししています。

世界の人口動態は、出生率の低下と医療の進歩による平均寿命の延長により、高齢化へと顕著にシフトしています。世界保健機関（WHO）によると、60歳以上の人口は2050年までに倍増し、世界で約21億人に達すると予想されています。この人口動態の変化は、高齢者における心血管疾患（CVD）を含む加齢関連疾患の有病率の増加を強調しています。米国心臓協会が2023年11月に発表した論文によると、心不全は広範かつ多面的な心血管系の疾患であり、670万人以上の米国人に影響を与え、特に65歳以上の高齢者の間で流行しています。心血管系疾患に罹患しやすい高齢化社会は、診断・治療手技の需要を促進し、市場成長を牽引しています。

医療機器の技術的進歩は、市場成長を促進する上で極めて重要です。材料、デザイン、機能の革新により、より効果的で信頼性の高い止血バルブが開発されています。例えば、先進的なポリマーやコーティングを使用することで、これらのデバイスの耐久性や生体適合性が向上し、血栓症や感染症などの合併症が減少しています。加えて、使いやすいロック機構や強化されたシーリング能力などの新しい機能を取り入れることで、臨床現場における止血バルブの効率が向上しています。例えば、Boston Scientific CorporationのWATCHDOG止血バルブは、リークを最小限に抑える革新的なクロススリット設計を採用し、複数のデバイスを同時に収容できる8Fの内腔を備えています。さらに、手技中の快適性を高めるために設計されたサムレスト機能も備えています。このような設計要素により、出血量と空気塞栓症のリスクを低減し、医療処置全体を通じて患者の安全を最優先しています。

を優先しています。このような技術的改善により、手技がより安全かつ効率的になり、止血バルブの採用が促進されます。

世界の止血バルブの市場セグメンテーション

本レポートでは、2018～2030年の収益成長と各サブセグメントにおける最新動向の分析を予測しています。本レポートでは、Grand View Research, Inc.は世界の止血バルブ市場レポートをタイプ、用途、最終用途、地域に基づいてセグメント化しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 止血バルブ市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 補助市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 業界分析-ポーターのファイブフォース分析
    • PESTEL分析
  • COVID-19による止血バルブ市場への影響
  • 価格分析

第4章 止血バルブ市場：タイプ別、推定・動向分析

  • セグメントダッシュボード
  • 止血バルブ市場：タイプ変動分析、2023年と2030年

第5章 止血バルブ市場：用途別、推定・動向分析

  • セグメントダッシュボード
  • 止血バルブ市場：用途変動分析、2023年と2030年

第6章 止血バルブ市場：最終用途別、推定・動向分析

  • セグメントダッシュボード
  • 止血バルブ市場：最終用途変動分析、2023年と2030年

第7章 止血バルブ市場：地域推定・動向分析

  • 地域別市場シェア分析、2023年と2030年
  • 地域市場ダッシュボード
  • 世界地域市場スナップショット
  • 市場規模と予測動向分析、2018～2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要企業の市場シェア分析、2023年
    • Boston Scientific Corporation
    • Teleflex Incorporated
    • Merit Medical Systems
    • B. Braun Melsungen AG
    • TERUMO CORPORATION
    • Abbott
    • Argon Medical Devices
    • Freudenberg Medical
    • SCW Medicath Ltd
    • Lepu Medical Technology（Beijing）Co.,Ltd.
    • Nipro
    • DeRoyal Industries, Inc.
    • Antmed Corporation
    • Beijing Demax Medical Technology Co
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness Highest Growth
  • Table 4 Global Hemostasis Valve Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 6 Global Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Global Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 8 North America Hemostasis Valve Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 North America Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 11 North America Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 12 U.S. Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 U.S. Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15 Canada Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 16 Canada Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 17 Canada Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 18 Europe Hemostasis Valve Market, By Country, 2018 - 2030 (USD Million)
  • Table 19 Europe Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 20 Europe Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 21 Europe Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 22 UK Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 UK Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 UK Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 25 Germany Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 Germany Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 27 Germany Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28 France Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 29 France Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 France Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 31 Italy Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 Italy Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 Italy Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 34 Spain Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 Spain Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Spain Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37 Denmark Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 38 Denmark Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 Denmark Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 40 Sweden Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 41 Sweden Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 42 Sweden Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 43 Norway Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 44 Norway Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 45 Norway Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Hemostasis Valve Market, By Country, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 50 Japan Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Japan Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 Japan Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 53 China Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 China Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 China Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56 India Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 57 India Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 India Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 59 South Korea Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 South Korea Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 61 South Korea Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 62 Australia Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 63 Australia Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 64 Australia Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65 Thailand Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 66 Thailand Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 67 Thailand Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 68 Latin America Hemostasis Valve Market, By Country, 2018 - 2030 (USD Million)
  • Table 69 Latin America Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 70 Latin America Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 71 Latin America Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 72 Brazil Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 73 Brazil Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 74 Brazil Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 75 Argentina Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 76 Argentina Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 77 Argentina Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 78 Mexico Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 79 Mexico Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 80 Mexico Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 81 Middle East and Africa Hemostasis Valve Market, By Country, 2018 - 2030 (USD Million)
  • Table 82 Middle East and Africa Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 83 Middle East and Africa Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 85 South Africa Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 86 South Africa Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 87 South Africa Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 91 UAE Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 92 UAE Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 93 UAE Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Hemostasis Valve Market, By Type, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Hemostasis Valve Market, By Application, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Hemostasis Valve Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Hemostasis Valve market segment scope and defination
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2023)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Hemostasis valve market: Type movement analysis
  • Fig. 17 Hemostasis valve market: Type segment dashboard
  • Fig. 18 Hemostasis valve market Type outlook: Key takeaways
  • Fig. 19 Hemostasis valve Y- connectors hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Double Y- Connector hemostasis valves market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 One- Handed hemostasis valves market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Tissue retractors hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Other hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Hemostasis Valve market: Application movement analysis
  • Fig. 25 Hemostasis Valve market Application outlook: Key takeaways
  • Fig. 26 Angiography hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Angioplasty hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Hemostasis Valve market: End use movement analysis
  • Fig. 29 Hemostasis Valve market End use outlook: Key takeaways
  • Fig. 30 Hospitals Hemostasis Valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Ambulatory surgical centers hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Other hemostasis valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Regional outlook, 2023 & 2030
  • Fig. 34 Regional market dashboard
  • Fig. 35 Regional market place: Key takeaways
  • Fig. 36 North America Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 40 UK Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 43 France Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy implantable Market, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 49 Japan Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 50 China Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 51 India Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 53 Australia Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 57 Mexico Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 59 MEA Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 61 Saudi Arabia Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 62 UAE Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 63 Kuwait Hemostasis Valve Market, 2018 - 2030 (USD Million)
  • Fig. 64 Heat map analysis
  • Fig. 65 Market differentiators
目次
Product Code: GVR-4-68040-342-2

Hemostasis Valve Market Size & Trends

The global hemostasis valve market size was estimated at USD 174.8 million in 2023 and is projected to grow at a CAGR of 5.8% from 2024 to 2030. The increasing prevalence of cardiovascular diseases, supportive regulatory frameworks, rising geriatric population, and technological advancements are significantly driving the market growth. According to the report published by World Heart Federation in 2023, cardiovascular diseases (CVDs) have a profound global impact, affecting over half a billion people worldwide and resulting in approximately 20.5 million deaths in 2021.This, in turn, drives the demand for diagnostic and therapeutic procedures like angiography and angioplasty, where hemostasis valves are essential to ensure patient safety by controlling blood flow during catheterization procedures.

The growing preference for minimally invasive procedures is another significant factor propelling the market growth. Minimally invasive techniques offer numerous benefits over traditional open surgeries, including reduced pain, shorter hospital stays, faster recovery times, and lower risk of complications. As a result, there is a heightened demand for medical devices that facilitate these procedures. Hemostasis valves are integral to minimally invasive catheter-based interventions, as they enable precise control of blood flow and prevent leakage during the procedure. The shift towards minimally invasive techniques in cardiology and other medical fields drives the adoption of hemostasis valves.

The global demographic landscape is undergoing a notable shift towards aging, driven by declining birth rates and advancements in healthcare that have prolonged life expectancy. According to the World Health Organization (WHO), the number of people aged 60 years and older is expected to double by 2050, reaching approximately 2.1 billion globally. This demographic transition underscores the increasing prevalence of age-related conditions, including cardiovascular diseases (CVDs) among older adults. According to the article published by the American Heart Association in November 2023, heart failure is a widespread and multifaceted cardiovascular condition impacting more than 6.7 million Americans, particularly prevalent among individuals aged 65 and older. The aging population is susceptibility to cardiovascular diseases drive the demand for diagnostic and therapeutic procedures, driving the market growth.

Technological advancements in medical devices are pivotal in driving the market growth. Materials, design, and functionality innovations have developed more effective and reliable hemostasis valves. For instance, using advanced polymers and coatings has improved the durability and biocompatibility of these devices, reducing complications such as thrombosis and infection. In addition, incorporating novel features such as easy-to-use locking mechanisms and enhanced sealing capabilities has increased the efficiency of hemostasis valves in clinical settings. For instance, the WATCHDOG Hemostasis Valve by Boston Scientific Corporation incorporates an innovative cross-slit design to minimize leakage, complemented by an 8F inner lumen that simultaneously accommodates multiple devices. In addition, it includes a thumb rest feature designed for enhanced comfort during procedures. The design elements collectively contribute to reducing blood loss and the risk of air embolism, prioritizing patient safety throughout medi

cal interventions. These technological improvements ensure that procedures are safer and more efficient, boosting the adoption of hemostasis valves.

Global Hemostasis Valve Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global hemostasis valve market report based on type, application, end-use, and regions.

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Hemostasis Valve Y- Connectors
  • Double Y- Connector Hemostasis Valves
  • One- Handed Hemostasis Valves
  • Others
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Angiography
  • Angioplasty
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

Japan

China

India

South Korea

Australia

Thailand

  • Latin America

Brazil

Argentina

  • Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hemostasis Valve Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Industry Analysis - Porter's
      • 3.2.3.1. Bargaining power of the suppliers
      • 3.2.3.2. Bargaining power of the buyers
      • 3.2.3.3. Threats of substitution
      • 3.2.3.4. Threats from new entrants
      • 3.2.3.5. Competitive rivalry
    • 3.2.4. PESTEL Analysis
      • 3.2.4.1. Political landscape
      • 3.2.4.2. Economic and Social landscape
      • 3.2.4.3. Technological landscape
  • 3.3. Impact of COVID-19 on the Hemostasis Valve Market
  • 3.4. Pricing Analysis

Chapter 4. Hemostasis Valve Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Hemostasis Valve Market: Type Movement Analysis, 2023 & 2030 (USD Million)
    • 4.2.1. Hemostasis Valve Y- Connectors
      • 4.2.1.1. Hemostasis Valve Y- Connectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. Double Y - Connector Hemostasis Valves
      • 4.2.2.1. Double Y - Connector Hemostasis Valves Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.3. One-Handed Hemostasis Valves
      • 4.2.3.1. One-Handed Hemostasis Valves Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.4. Others
      • 4.2.4.1. Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Hemostasis Valve Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Hemostasis Valve Market: Application Movement Analysis, 2023 & 2030 (USD Million)
    • 5.2.1. Angiography
      • 5.2.1.1. Angiography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.2. Angioplasty
      • 5.2.2.1. Angioplasty Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.3. Angioplasty
      • 5.2.3.1. Angioplasty Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Hemostasis Valve Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Hemostasis Valve Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
    • 6.2.1. Hospitals
      • 6.2.1.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. Ambulatory Surgical Centers
      • 6.2.2.1. Ambulatory Surgical Centers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Others
      • 6.2.3.1. Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Hemostasis Valve Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key company market share analysis, 2023
    • 8.3.2. Boston Scientific Corporation
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Type benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Teleflex Incorporated
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Type benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Merit Medical Systems
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Type benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. B. Braun Melsungen AG
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Type benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. TERUMO CORPORATION
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Type benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Abbott
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Type benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Argon Medical Devices
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Type benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Freudenberg Medical
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Type benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. SCW Medicath Ltd
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Type benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Lepu Medical Technology (Beijing)Co.,Ltd.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Type benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Nipro
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Type benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. DeRoyal Industries, Inc.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Type benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Antmed Corporation
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Type benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. Beijing Demax Medical Technology Co
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Type benchmarking
      • 8.3.15.4. Strategic initiatives